Tone Andersen-Hollekim1, Bodil J Landstad2,3, Marit Solbjør4, Marit Kvangarsnes5, Torstein Hole6. 1. Department of Circulation and Medical Imaging, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Trondheim, Norway. tone.elisabeth.andersen@helse-mr.no. 2. Department of Health Sciences, Mid Sweden University, Östersund, Sweden. 3. Nord-Trøndelag Hospital Trust, Levanger Hospital, Levanger, Norway. 4. Department of Public Health and Nursing, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Trondheim, Norway. 5. Department of Health Sciences, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Ålesund, Norway. 6. Department of Circulation and Medical Imaging, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Trondheim, Norway.
Abstract
BACKGROUND: For individuals in need of dialysis, patient participation is important when determining care goals and in decision making regarding dialysis modality. Nephrologists hold a key role in delivering evidence-based healthcare that integrates patient preferences and values throughout the trajectory, and their experiences with patient participation are important for improving health care. The aim of this study was to explore nephrologists' experiences with patient participation in different phases of the end-stage renal disease trajectory for working-age individuals who require dialysis. METHODS: This explorative study comprised interviews with ten nephrologists from four different dialysis units in Central Norway. We analysed the interviews by applying an interpretive phenomenological approach. RESULTS: Nephrologists had varied experiences with patient participation throughout the different phases of the treatment trajectory. During decision making on the dialysis modality, nephrologists emphasised patients' choices in two approaches. In the first approach, they expected patients to choose the modality based on the provided information, which could be actively steered. In the second approach, they recognised the patients' values and lifestyle preferences through shared decision-making. Within hospital haemodialysis, nephrologists considered patients' self-care activities equivalent to patient participation, seeing self-care as a source of patient empowerment. They identified divergent patient-professional values and organisational structures as barriers to patient participation. CONCLUSION: Our study shows that nephrologists have different approaches to patient participation in different phases of the end-stage renal disease trajectory. Individual understanding as well as organisational structures are important factors to address to increase patient participation in end-stage renal disease care. Shared decision making, in which patient values are balanced against biomedical treatment targets, allows for mutual agreement between patients and healthcare professionals concerning medical plans and minimises the potential for patient-professional tensions.
BACKGROUND: For individuals in need of dialysis, patient participation is important when determining care goals and in decision making regarding dialysis modality. Nephrologists hold a key role in delivering evidence-based healthcare that integrates patient preferences and values throughout the trajectory, and their experiences with patient participation are important for improving health care. The aim of this study was to explore nephrologists' experiences with patient participation in different phases of the end-stage renal disease trajectory for working-age individuals who require dialysis. METHODS: This explorative study comprised interviews with ten nephrologists from four different dialysis units in Central Norway. We analysed the interviews by applying an interpretive phenomenological approach. RESULTS: Nephrologists had varied experiences with patient participation throughout the different phases of the treatment trajectory. During decision making on the dialysis modality, nephrologists emphasised patients' choices in two approaches. In the first approach, they expected patients to choose the modality based on the provided information, which could be actively steered. In the second approach, they recognised the patients' values and lifestyle preferences through shared decision-making. Within hospital haemodialysis, nephrologists considered patients' self-care activities equivalent to patient participation, seeing self-care as a source of patient empowerment. They identified divergent patient-professional values and organisational structures as barriers to patient participation. CONCLUSION: Our study shows that nephrologists have different approaches to patient participation in different phases of the end-stage renal disease trajectory. Individual understanding as well as organisational structures are important factors to address to increase patient participation in end-stage renal disease care. Shared decision making, in which patient values are balanced against biomedical treatment targets, allows for mutual agreement between patients and healthcare professionals concerning medical plans and minimises the potential for patient-professional tensions.
Authors: Christopher T Chan; Peter J Blankestijn; Laura M Dember; Maurizio Gallieni; David C H Harris; Charmaine E Lok; Rajnish Mehrotra; Paul E Stevens; Angela Yee-Moon Wang; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Carol A Pollock Journal: Kidney Int Date: 2019-04-13 Impact factor: 10.612
Authors: Allison Tong; Wolfgang C Winkelmayer; David C Wheeler; Wim van Biesen; Peter Tugwell; Braden Manns; Brenda Hemmelgarn; Tess Harris; Sally Crowe; Angela Ju; Emma O'Lone; Nicole Evangelidis; Jonathan C Craig Journal: Clin J Am Soc Nephrol Date: 2017-02-21 Impact factor: 8.237
Authors: Yves Longtin; Hugo Sax; Lucian L Leape; Susan E Sheridan; Liam Donaldson; Didier Pittet Journal: Mayo Clin Proc Date: 2010-01 Impact factor: 7.616
Authors: Keren Ladin; Renuka Pandya; Ronald D Perrone; Klemens B Meyer; Allison Kannam; Rohini Loke; Tira Oskoui; Daniel E Weiner; John B Wong Journal: Clin J Am Soc Nephrol Date: 2018-07-26 Impact factor: 8.237
Authors: Nwamaka D Eneanya; Sarah L Goff; Talaya Martinez; Natalie Gutierrez; Jamie Klingensmith; John L Griffith; Casey Garvey; Jenny Kitsen; Michael J Germain; Lisa Marr; Joan Berzoff; Mark Unruh; Lewis M Cohen Journal: BMC Palliat Care Date: 2015-06-12 Impact factor: 3.234
Authors: Jerôme Jean Jacques van Dongen; Stephanie Anna Lenzen; Marloes Amantia van Bokhoven; Ramon Daniëls; Trudy van der Weijden; Anna Beurskens Journal: BMC Fam Pract Date: 2016-05-28 Impact factor: 2.497